Hepatic dysfunction after shock: Clinical parameters and biological pathways for therapeutic intervention

References

• Kiernan F. The anatomy and physiology of the liver. Philos Trans R Soc London 1833;123:711–70.
   Google Scholar
• Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979; 24: 129–35
   PubMed Web of Science ®Google Scholar
• Arcidi JM, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 patients at autopsy. Am J Pathol 1981; 104: 1159–66
   Google Scholar
• Henrion J, Luwaert R, Colin L, Schmitz A, Schapira M, Heller FR. Hypoxic hepatitis. Prospective, clinical and hemodynamic study of 45 cases. Gastroenterol Clin Biol 1990;14:836–41 (in French).
   Google Scholar
• Birrer R, Takuda Y, Takar T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007; 46: 1063–70
   PubMed Web of Science ®Google Scholar
• Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 2007; 35: 1099–104
   PubMed Web of Science ®Google Scholar
• Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262: 393–401
   PubMed Web of Science ®Google Scholar
• Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 2006; 32: 267–74
   PubMed Web of Science ®Google Scholar
• Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82: 392–406
   PubMed Web of Science ®Google Scholar
• Harbrecht BG, Zenati MS, Doyle HR, McMichael J, Townsend RN, Clancy KD, et al. Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 2002; 53: 517–23
   Google Scholar
• Rashed KA, McNabb WR, Lewis RR. Ischaemic hepatitis in the elderly. Gerontology 2002; 48: 245–9
   Google Scholar
• Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109–13
   PubMed Web of Science ®Google Scholar
• Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999; 45: 129–33
   PubMed Web of Science ®Google Scholar
• Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26: 183–6
   PubMed Web of Science ®Google Scholar
• Gibson PR, Dudley FJ. Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust N Z J Med 1984; 14: 822–5
   PubMedGoogle Scholar
• Kubo SH, Walter BA, John DH, Clark M, Cody RJ. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 1987; 147: 1227–30
   PubMedGoogle Scholar
• Peralta C, Bulbena O, Xaus C, Prats N, Cutrin JC, Poli G. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002; 73: 1203–11
   PubMed Web of Science ®Google Scholar
• Rudiger HA, Graf R, Clavien PA. Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J Hepatol 2003; 39: 972–7
   Google Scholar
• Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843–50
   PubMed Web of Science ®Google Scholar
• Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006; 244: 921–8
   PubMedGoogle Scholar
• Dahn MS, Wilson RF, Lange P, Stone A, Jacobs LA. Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 1990; 125: 441–3
   Google Scholar
• Zhang H, Vincent JL. Oxygen extraction is altered by endotoxin during tamponade-induced stagnant hypoxia in the dog. Circ Shock 1993; 40: 168–76
   Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301–5
   PubMed Web of Science ®Google Scholar
• Yang R, Gallo DJ, Baust JJ, Watkins SK, Delude RL, Fink MP. Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice. Am J Physiol Regul Integr Comp Physiol 2002; 283: R1263–74
   PubMed Web of Science ®Google Scholar
• Wang H, Li ZY, Wu HS, Wang Y, Jiang CF, Zheng QC, et al. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway. Chin Med J (Engl) 2007; 120: 509–14
   PubMedGoogle Scholar
• Weigand K, Riediger C, Stremmel W, Flechtenmacher C, Encke J. Are heat stroke and physical exhaustion underestimated causes of acute hepatic failure?. World J Gastroenterol 2007; 13: 306–9
   PubMedGoogle Scholar
• Tadros T, Traber DL, Herndon DN. Hepatic blood flow and oxygen consumption after burn and sepsis. J Trauma 2000; 49: 101–8
   Google Scholar
• Zhang H, Smail N, Cabral A, Cherkaoui S, Peny MO, Vincent JL. Hepato-splanchnic blood flow and oxygen extraction capabilities during experimental tamponade: effects of endotoxin. J Surg Res 1999; 81: 129–38
   Google Scholar
• Zhang H, De Jongh R, De Backe D, Cherkaoui S, Vray B, Vincent JL. Effects of alpha- and beta-adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock. Crit Care Med 2001; 29: 581–8
   Web of Science ®Google Scholar
• Rocheleau B, Ethier C, Houle R, Huet PM, Bilodeau M. Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 1999; 277: G1000–7
   Google Scholar
• Ezzat WR, Lautt WW. Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol 1987; 252: H836–45
   PubMed Web of Science ®Google Scholar
• Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, Tanaka H, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997; 63: 217–23
   PubMedGoogle Scholar
• Jungermann K, Kietzmann T. Role of oxygen in the zonation of carbohydrate metabolism and gene expression in liver. Kidney Int 1997; 51: 402–12
   PubMedGoogle Scholar
• Eum HA, Cha YN, Lee SM. Necrosis and apoptosis: sequence of liver damage following reperfusion after 60 min ischemia in rats. Biochem Biophys Res Commun 2007; 358: 500–5
   Google Scholar
• Heijnen BH, Straatsburgh IH, Padilla ND, Van Mierlo GJ, Hack CE, Van Gulik TM. Inhibition of classical complement activation attenuates liver ischemia and reperfusion injury in a rat model. Clin Exp Immunol 2006; 143: 15–23
   PubMed Web of Science ®Google Scholar
• Rensing H, Bauer I, Zhang JX, Paxian M, Pannen BH, Yokoyama Y, et al. Endothelin-1 and heme oxygenase-1 as modulators of sinusoidal tone in the stress-exposed rat liver. Hepatology 2002; 36: 1453–65
   Google Scholar
• Hanazaki K, Kuroda T, Haba Y, Shiohara E, Kajikawa S, Iida F. Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. Surgery 1994; 116: 896–903
   Google Scholar
• Hossain MA, Wakabayashi H, Izuishi K, Okano K, Yachida S, Maeta H. The role of prostaglandins in liver ischemia-reperfusion injury. Curr Pharm Des 2006; 12: 2935–51
   PubMedGoogle Scholar
• Cottart CH, Do L, Blanc MC, Vaubourdolle M, Descamps G, Durand D, et al. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 1999; 29: 809–13
   PubMed Web of Science ®Google Scholar
• Rensing H, Bauer I, Kubulus D, Wolf B, Winning J, Ziegeler S, et al. Heme oxygenase-1 gene expression in pericentral hepatocytes through beta 1-adrenoceptor stimulation. Shock 2004; 21: 376–87
   PubMed Web of Science ®Google Scholar
• Samarasinghe DA, Farrell GC. The central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat. Hepatology 1996; 24: 1230–7
   Google Scholar
• Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol 2003; 17: 369–81
   PubMed Web of Science ®Google Scholar
• Sundar SV, Li YY, Rollwagen FM, Maheshwari RK. Hemorrhagic shock induces differential gene expression and apoptosis in mouse liver. Biochem Biophys Res Commun 2005; 332: 688–96
   PubMed Web of Science ®Google Scholar
• De Faatima Santana Ferreira Boin I, de Castro e Silva O, de Souza ME, Santos AC, Leonardi LS. Pyruvate kinase activation and lipoperoxidation after selective hepatic ischemia in Wistar rats. Acta Cir Bras 2006; 21(Suppl 1)19–23
   Google Scholar
• Yokoyama Y, Kitchens WC, Toth B, Schwacha MG, Rue LW 3rd, Bland KI, et al. Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage. Am J Physiol Gastrointest Liver Physiol 2004; 286: G942–6
   PubMed Web of Science ®Google Scholar
• Rajnik M, Salkowski CA, Thomas KE, Li YY, Rollwagen FM, Vogel SN. Induction of early inflammatory gene expression in a murine model of nonresuscitated, fixed-volume hemorrhage. Shock 2002; 17: 322–8
   PubMedGoogle Scholar
• Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, et al. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999; 30: 1448–53
   PubMed Web of Science ®Google Scholar
• Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem 1999; 274: 23013–9
   PubMed Web of Science ®Google Scholar
• Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW 3rd, Bland KI, et al. Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 2004; 97: 2184–9
   PubMed Web of Science ®Google Scholar
• Matsutani T, Kang SC, Miyashita M, Sasajima K, Choudhry MA, Bland KI, et al. Liver cytokine production and ICAM-1 expression following bone fracture, tissue trauma, and hemorrhage in middle-aged mice. Am J Physiol Gastrointest Liver Physiol 2007; 292: G268–74
   Google Scholar
• Shi YF, Fong CC, Zhang Q, Cheung PY, Tzang CH, Wu RS, et al. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett 2007; 581: 203–10
   PubMedGoogle Scholar
• Paxian M, Bauer I, Rensing H, Jaeschke H, Mautes AEM, Kolb SA, et al. Recovery of hepatocellular ATP and “pericentral apoptosis” after hemorrhage and resuscitation. FASEB J 2003; 17: 993–1002
   Google Scholar
• Gores GJ, Nieminen AL, Wray BE, Herman B, Lemasters JJ. Intracellular pH during “chemical hypoxia” in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J Clin Invest 1989; 83: 386–96
   PubMedGoogle Scholar
• Qian T, Nieminen AL, Herman B, Lemasters JJ. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 1997; 273: C1783–92
   PubMed Web of Science ®Google Scholar
• Kim JS, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology 2003; 124: 494–503
   Google Scholar
• Vilatoba M, Eckstein C, Bilbao G, Smyth CA, Jenkins S, Thompson JA, et al. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 2005; 138: 342–51
   PubMed Web of Science ®Google Scholar
• Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM, Belous AE, et al. 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake. Am J Physiol Gastrointest Liver Physiol 2007; 293: G623–30
   Google Scholar
• Morin D, Pires F, Plin C, Tillement JP. Role of the permeability transition pore in cytochrome C release from mitochondria during ischemia-reperfusion in rat liver. Biochem Pharmacol 2004; 68: 2065–73
   Google Scholar
• Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006; 43: S31–44
   PubMed Web of Science ®Google Scholar
• Reinehr R, Becker S, Wettstein M, Haussinger D. Involvement of the Src family kinase yes in bile salt-induced apoptosis. Gastroenterology 2004; 127: 1540–57
   PubMedGoogle Scholar
• Cao L, Li Y, Cheng F, Li S, Long D. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocytes line. Transplant Proc 2006; 38: 2207–9
   Google Scholar
• David H, Ellermann J, Uerlings I. Primary phase of hepatocytic autophagocytosis under ischemic conditions. Exp Toxicol Pathol 1992; 44: 74–80
   PubMedGoogle Scholar
• Jarrar D, Wang P, Cioffi WG, Bland KI. Chaudry IH. Critical role of oxygen radicals in the initiation of hepatic depression after trauma hemorrhage. J Trauma 2000; 49: 879–85
   PubMedGoogle Scholar
• Karaman A, Fadillioglu E, Turkmen E, Tas E, Yilmaz Z. Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver. Pediatr Surg Int 2006; 22: 428–34
   PubMed Web of Science ®Google Scholar
• Shiotani S, Shimada M, Taketomi A, Soejima Y, Yoshizumi T, Hashimoto K, et al. Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system. Gene Ther 2007; 14: 1425–33
   PubMedGoogle Scholar
• Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, et al. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 2000; 14: 418–29
   PubMedGoogle Scholar
• Ding WX, Ni HM, DiFrancesca D, Stolz DB, Yin XM. Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology 2004; 40: 403–13
   PubMedGoogle Scholar
• Abdelrahman M, Mazzon E, Bauer M, Bauer I, Delbosc S, Cristol JP, et al. Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 2005; 23: 107–14
   PubMedGoogle Scholar
• Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135–43
   PubMed Web of Science ®Google Scholar
• Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakoa A, Chan MH, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661–8
   PubMed Web of Science ®Google Scholar
• Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, et al. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 2006; 202: 407–17
   PubMed Web of Science ®Google Scholar
• Hsieh YC, Frink M, Kawasaki T, Thobe BM, Choudhry MA, Schwacha MG, et al. Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage. J Cell Physiol 2007; 211: 364–70
   PubMed Web of Science ®Google Scholar
• Sun GB, Huang ZH, Sun YG, Yang WY. Intervention with nitric oxide synthase inhibitors for traumatic shock in rats. Di Yi Jun Yi Da Xue Xue Bao 2003; 23: 306–9
   Google Scholar
• Rivera-Chavez FA, Toledo-Pereyra LH, Dean RE, Crouch L, Ward PA. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J Invest Surg 2001; 14: 267–73
   PubMed Web of Science ®Google Scholar
• Hierhlozer C, Billiar TR, Tweardy DJ, Harbrecht B. Reduced hepatic transcription factor activation and expression of IL-6 and ICAM-1 after hemorrhage by NO scavenging. Arch Orthop Trauma Surg 2003; 123: 55–9
   Google Scholar
• Lee VG, Johnson ML, Baust J, Laubach VE, Watkins SC, Billiar TR. The roles of iNOS in liver ischemia-reperfusion injury. Shock 2001; 16: 355–60
   Google Scholar
• Cottart CH, Nivet-Antoine V, Do L, Al-Massarani G, Descamps G, Xavier-Galen F, et al. Hepatic cytoprotection by nitric oxide and the cGMP pathway after ischemia-reperfusion in the rat. Nitric Oxide 2003; 9: 57–63
   PubMedGoogle Scholar
• Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004; 39: 1533–43
   PubMedGoogle Scholar
• Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005; 5: 1793–800
   PubMedGoogle Scholar
• Tsuchihashi S, Zhai Y, Bo Q, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation 2007; 83: 1628–34
   PubMedGoogle Scholar
• Shen XD, Ke B, Zhai Y, Amersi F, Gao F, Anselmo DM, et al. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 2002; 74: 315–9
   PubMed Web of Science ®Google Scholar
• Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296–303
   PubMed Web of Science ®Google Scholar
• Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW. Interleukin 13 gene transfer in liver ischemia and reperfusion injury: role of Stat6 and TLR4 pathways in cytoprotection. Hum Gene Ther 2004; 15: 691–8
   Google Scholar
• Ohlmann A, Giffhorn-Katz S, Becker I, Katz N, Immenschuh S. Regulation of heme oxygenase-1 gene expression by anoxia and reoxygenation in primary rat hepatocytes cultures. Exp Biol Med (Maywood) 2003; 228: 584–9
   Google Scholar
• Mizushima Y, Wang P, Jarrar D, Cioffi WG, Bland KI, Chaudry IH. Preinduction of heat shock proteins protects cardiac and hepatic functions following trauma and hemorrhage. Am J Physiol Regul Integr Comp Physiol 2000; 278: R352–9
   Google Scholar
• Zuckerbraun BS, McCloskey CA, Gallo D, Liu F, Ifedigbo E, Otterbein LE, et al. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 2005; 23: 527–32
   Google Scholar
• Liu H, Lo CR, Czaja MJ. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 2002; 35: 772–8
   PubMed Web of Science ®Google Scholar
• McCloskey CA, Kameneva MV, Uryash A, Gallo DJ, Billiar TR. Tissue hypoxia activates JNK in the liver during hemorrhagic shock. Shock 2004; 22: 380–6
   PubMedGoogle Scholar
• Rao YP, Studer EJ, Stravitz RT, Gupta S, Qiao L, Dent P, et al. Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology 2002; 35: 307–14
   PubMed Web of Science ®Google Scholar
• Jarrar D, Song GY, Kuebler JF, Rue LW 3rd, Bland KI, Chaudry IH. The effect of inhibition of a major cell signaling pathway following trauma hemorrhage on hepatic injury and interleukin 6 levels. Arch Surg 2004; 139: 896–901
   Google Scholar
• Prince JM, Ming MJ, Levy RM, Liu S, Pinsky DJ, Vodovotz Y, et al. Early growth response 1 mediates the systemic and hepatic inflammatory response initiated by hemorrhagic shock. Shock 2007; 27: 157–64
   Google Scholar
• Cursio R, Filippa N, Miele C, Van Obberghen E, Gugenheim J. Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury. Br J Surg 2006; 93: 752–61
   Google Scholar
• Mullonkal CJ, Toledo-Pereyra LH. Akt in ischemia and reperfusion. J Invest Surg 2007; 20: 195–203
   PubMed Web of Science ®Google Scholar
• Ikeda H, Kume Y, Tejima K, Tomija T, Nishikawa T, Watanabe N, et al. Rho-kinase inhibitor prevents hepatocytes damage in acute liver injury induced by carbon tetrachloride in rats. Am J Physiol Gastrointest Liver Physiol 2007; 293: G911–7
   Google Scholar
• Grutzner U, Keller M, Bach M, Kiemer AK, Meissner H, Bilzer M, et al. PI 3-kinase pathway is responsible for antiapoptotic effects of atrial natriuretic peptide in rat liver transplantation. World J Gastroenterol 2006; 12: 1049–55
   PubMed Web of Science ®Google Scholar
• Potter JM, Hickman PE. Cardiodepressant drugs and the high mortality rate associated with ischemic hepatitis. Crit Care Med 1992; 20: 474–8
   Google Scholar
• Naschitz JE, Yeshurun D. Compensated cardiogenic shock: a subset with damage limited to liver and kidneys. The possible salutary effect of low-dose dopamine. Cardiology 1987; 74: 212–8
   Google Scholar
• Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis 2002; 6: 947–67
   PubMedGoogle Scholar
• Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852–7
   PubMed Web of Science ®Google Scholar
• Walsh TS, Hopton P, Philips BJ, Mackenzie SJ, Lee A. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 1998; 27: 1332–40
   PubMed Web of Science ®Google Scholar
• Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 2000; 28: 3799–807
   PubMed Web of Science ®Google Scholar
• Van de Kerkhove MP, Hoekstra R, Chamuleau RAFM, Van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216–30
   PubMed Web of Science ®Google Scholar
• Wolff B, Machill K, Schumacher D, Schulzki I. MARS dialysis in decompensated alcoholic liver disease: a single-center experience. Liver Transpl 2007; 13: 1189–92
   PubMed Web of Science ®Google Scholar
• Novelli G, Rossi M, Pretagostini R, Poli L, Novelli L, Berloco P, et al. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure. Liver 2002; 22: 43–7
   Google Scholar
• Izuishi K, Tsung A, Hossain MA, Fujiwara M, Wakabayashi H, Masaki T, et al. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 2006; 44: 573–80
   PubMed Web of Science ®Google Scholar
• Franco-Gou R, Rosello-Catafau J, Casillas-Ramirez A, Massip-Salcedo M, Rimola A, Calvo N, et al. How ischemic preconditioning protects small liver grafts. J Pathol 2006; 208: 62–73
   PubMed Web of Science ®Google Scholar
• Amador A, Grande L, Marti J, Deulofeu R, Miquel R, Sola A, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007; 7: 2180–9
   PubMed Web of Science ®Google Scholar
• Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006; 12: 628–35
   PubMed Web of Science ®Google Scholar
• Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem 1997; 40: 1947–54
   PubMed Web of Science ®Google Scholar
• Angele MK, Fitzal F, Smail N, Knoferl MW, Schwacha MG, Ayala A, et al. L-arginine attenuates trauma-hemorrhage-induced liver injury. Crit Care Med 2000; 28: 3242–8
   Google Scholar
• Nijveldt RJ, Siroen MP, van der Hoven B, Teerlink T, Prins HA, Girbes AR, et al. High plasma arginine concentrations in critically ill patients suffering from hepatic failure. Eur J Clin Nutr 2004; 58: 587–3
   Google Scholar
• Mauriz JL, Gonzalez P, Jorquera F, Olcoz JL, Gonzalez-Gallego J. Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock 2003; 19: 33–7
   PubMed Web of Science ®Google Scholar
• Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, et al. Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1538–44
   PubMed Web of Science ®Google Scholar
• Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 2005; 42: 850–9
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra LH, Lopez-Neblina F, Reuben JS, Toledo AH, Ward PA. Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion. J Invest Surg 2004; 17: 303–13
   PubMed Web of Science ®Google Scholar
• Kiang JG, Peckham RM, Duke LE, Shimizu T, Chaudry IH, Tsokos GC. Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway. J Appl Physiol 2007; 102: 933–41
   PubMedGoogle Scholar
• Kuebler JF, Yokoyama Y, Jarrar D, Toth B, Rue LW 3rd, Bland KI, et al. Administration of progesterone after trauma and hemorrhagic shock prevents hepatocellular injury. Arch Surg 2003; 138: 727–34
   PubMed Web of Science ®Google Scholar
• Schimizu T, Yu HP, Suzuki T, Szalay L, Hsieh YC, Choudhry MR, et al. The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhage. J Hepatol 2007; 46: 1047–54
   Google Scholar
• Eckoff DE, Bilbao G, Frenette L, Thompson JA, Contreras JL. 17-Beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002; 132: 302–9
   Google Scholar